Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Silo Pharma宣佈以納斯達克規則定價的市價註冊直接發行價值210萬美元已經結束
Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Silo Pharma宣佈以納斯達克規則定價的市價註冊直接發行價值210萬美元已經結束
使用瀏覽器的分享功能,分享給你的好友吧